ArticleScientific reports2025
Evaluation of cytotoxicity and anti-inflammatory action of AH-Plus sealer with and without petasin, pachymic acid, curcumin & shilajit: an invitro-study.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Biogeochemical Evaluation of Shilajit: Testosterone-Modulating Effects, In Vivo Toxicity and Lipid Profile Analysis.Pharmaceuticals (Basel, Switzerland) · 2026Article
- Article
- Comparative study of triterpene compounds in different processedFood chemistry: X · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
AH Plus, an epoxy resin-based sealer extensively employed in endodontics, is renowned for its excellent dimensional stability and effective adhesion to dentin. Nevertheless, extensive clinical research has documented its propensity to induce inflammation, especially when freshly mixed. Phytochemicals such as petasin, pachymic acid, curcumin, and shilajit are known for their anti-inflammatory and analgesic properties. This study aimed to investigate the influence of these phytochemicals on cytotoxicity and anti-inflammatory potential of AH Plus. Experimental groups included AH Plus-resin sealer (AHR) with and without 10% petasin (AHP), 0.75% pachymic acid (AHA), 0.5% curcumin (AHC) and 6% shilajit (AHS) at ratios of 5:1 and 10:1 respectively. Stem cells of apical papilla (SCAP) were exposed to the experimental sealers and assessed for cytotoxicity (MTT assay) and cytokine expression levels of IL-6, IL-8 and TNF-α (ELISA) at different time intervals (0 h, 24 h and 48 h). Experiments were performed in triplicate and analyzed using one-way ANOVA (p < 0.05). All experimental groups demonstrated varying levels of decreased cytotoxicity and cytokine expression compared to the control group; specifically in 5:1 ratio. Thus, it can be concluded that addition of petasin, pachymic acid, curcumin, and shilajit with AH Plus sealer in 5:1 ratio resulted in decreased cytotoxicity and enhanced anti-inflammatory properties.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.